APA (7th ed.) Citation

Zhang, J., & Li, W. Real-world pharmacovigilance analysis unveils the toxicity profile of amivantamab targeting EGFR exon 20 insertion mutations in non-small cell lung cancer. BMC.

Chicago Style (17th ed.) Citation

Zhang, Jing, and Wenjie Li. Real-world Pharmacovigilance Analysis Unveils the Toxicity Profile of Amivantamab Targeting EGFR Exon 20 Insertion Mutations in Non-small Cell Lung Cancer. BMC.

MLA (9th ed.) Citation

Zhang, Jing, and Wenjie Li. Real-world Pharmacovigilance Analysis Unveils the Toxicity Profile of Amivantamab Targeting EGFR Exon 20 Insertion Mutations in Non-small Cell Lung Cancer. BMC.